In the other respective sample obtained from a male patient with a cancer of unknown primary most likely deriving from a triple-negative breast cancer the PD-L1 status of the tumor-infiltrating lymphocytes was negative, but 2% of the tumor cells were PD-L1 positive. This evidence concerns the gene CD274 and triple-negative breast carcinoma.